Core Reckitt Business is Strong, With Attractive Margins -- Market Talk
Dow Jones
Dec 01, 2025
0914 GMT - Reckitt's core business is strong, with brands including Nurofen and Durex part of a smaller but faster-growing business, Barclays analysts write as they raise the rating on the stock to overweight from equal weight. Better performance in developed markets, as well as growth potential in the intimate-wellness space, also bode well for the U.K. consumer-goods group, they say. "'Core Reckitt' is a business with attractive margins and a particularly consistent 60% gross margin profile," the analysts write. Barclays raises the stock's target price to 70 pounds from 63 pounds. Shares are up 1.9% at 59.64 pounds. (josephmichael.stonor@wsj.com)
(END) Dow Jones Newswires
December 01, 2025 04:14 ET (09:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.